These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 34139148
1. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies. Anichina K, Argirova M, Tzoneva R, Uzunova V, Mavrova A, Vuchev D, Popova-Daskalova G, Fratev F, Guncheva M, Yancheva D. Chem Biol Interact; 2021 Aug 25; 345():109540. PubMed ID: 34139148 [Abstract] [Full Text] [Related]
2. Modulation Effect on Tubulin Polymerization, Cytotoxicity and Antioxidant Activity of 1H-Benzimidazole-2-Yl Hydrazones. Argirova M, Guncheva M, Momekov G, Cherneva E, Mihaylova R, Rangelov M, Todorova N, Denev P, Anichina K, Mavrova A, Yancheva D. Molecules; 2022 Dec 29; 28(1):. PubMed ID: 36615483 [Abstract] [Full Text] [Related]
3. Antiproliferative and Pro-Apoptotic Activity and Tubulin Dynamics Modulation of 1H-Benzimidazol-2-yl Hydrazones in Human Breast Cancer Cell Line MDA-MB-231. Yancheva D, Argirova M, Georgieva I, Milanova V, Guncheva M, Rangelov M, Todorova N, Tzoneva R. Molecules; 2024 May 20; 29(10):. PubMed ID: 38792260 [Abstract] [Full Text] [Related]
4. Synthesis, biological evaluation, and molecular docking studies of novel 1-benzene acyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as potential tubulin polymerization inhibitors. Wang YT, Qin YJ, Yang N, Zhang YL, Liu CH, Zhu HL. Eur J Med Chem; 2015 Jun 24; 99():125-37. PubMed ID: 26070164 [Abstract] [Full Text] [Related]
5. (E)-N-Aryl-2-oxo-2-(3,4,5-trimethoxyphenyl)acetohydrazonoyl cyanides as tubulin polymerization inhibitors: Structure-based bioisosterism design, synthesis, biological evaluation, molecular docking and in silico ADME prediction. Wang G, Peng Z, Peng S, Qiu J, Li Y, Lan Y. Bioorg Med Chem Lett; 2018 Nov 01; 28(20):3350-3355. PubMed ID: 30197030 [Abstract] [Full Text] [Related]
10. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Wang YT, Shi TQ, Zhu HL, Liu CH. Bioorg Med Chem; 2019 Feb 01; 27(3):502-515. PubMed ID: 30606674 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Donthiboina K, Anchi P, Gurram S, Sai Mani G, Lakshmi Uppu J, Godugu C, Shankaraiah N, Kamal A. Bioorg Chem; 2020 Oct 01; 103():104191. PubMed ID: 32891862 [Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of podophyllotoxin congeners as tubulin polymerization inhibitors. Kamal A, Srinivasa Reddy T, Polepalli S, Shalini N, Reddy VG, Subba Rao AV, Jain N, Shankaraiah N. Bioorg Med Chem; 2014 Oct 01; 22(19):5466-75. PubMed ID: 25131956 [Abstract] [Full Text] [Related]
14. Development of Benzimidazole-Substituted Spirocyclopropyl Oxindole Derivatives as Cytotoxic Agents: Tubulin Polymerization Inhibition and Apoptosis Inducing Studies. Sakla AP, Bazaz MR, Mahale A, Sharma P, Valapil DG, Kulkarni OP, Dandekar MP, Shankaraiah N. ChemMedChem; 2024 Jun 17; 19(12):e202400052. PubMed ID: 38517377 [Abstract] [Full Text] [Related]
15. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors. Behbahani FS, Tabeshpour J, Mirzaei S, Golmakaniyoon S, Tayarani-Najaran Z, Ghasemi A, Ghodsi R. Arch Pharm (Weinheim); 2019 Jun 17; 352(6):e1800307. PubMed ID: 31012156 [Abstract] [Full Text] [Related]
16. Synthesis and evaluation of benzimidazole carbamates bearing indole moieties for antiproliferative and antitubulin activities. Guan Q, Han C, Zuo D, Zhai M, Li Z, Zhang Q, Zhai Y, Jiang X, Bao K, Wu Y, Zhang W. Eur J Med Chem; 2014 Nov 24; 87():306-15. PubMed ID: 25262051 [Abstract] [Full Text] [Related]
17. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors. Wang YT, Cai XC, Shi TQ, Zhang YL, Wang ZC, Liu CH, Zhu HL. Chem Biol Drug Des; 2017 Jul 24; 90(1):112-118. PubMed ID: 28032450 [Abstract] [Full Text] [Related]
18. Design, synthesis, and biological evaluation of novel 2,3-Di-O-Aryl/Alkyl sulfonate derivatives of l-ascorbic acid: Efficient access to novel anticancer agents via in vitro screening, tubulin polymerization inhibition, molecular docking study and ADME predictions. Deshmukh SR, Nalkar AS, Sarkate AP, Tiwari SV, Lokwani DK, Thopate SR. Bioorg Chem; 2024 Jun 24; 147():107402. PubMed ID: 38688199 [Abstract] [Full Text] [Related]
19. Design, synthesis and biological evaluation of colchicine glycoconjugates as tubulin polymerization inhibitors. Wang Z, Liu R, Zhang X, Chang X, Gao M, Zhang S, Guan Q, Sun J, Zuo D, Zhang W. Bioorg Med Chem; 2022 Mar 15; 58():116671. PubMed ID: 35193066 [Abstract] [Full Text] [Related]
20. Design, synthesis, biological and in silico evaluation of coumarin-hydrazone derivatives as tubulin targeted antiproliferative agents. Govindaiah P, Dumala N, Mattan I, Grover P, Jaya Prakash M. Bioorg Chem; 2019 Oct 15; 91():103143. PubMed ID: 31374528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]